|
FY2021
12 months to Jun 30, 2021
|
FY2020
12 months to Jun 30, 2020
|
FY2019
12 months to Jun 30, 2019
|
FY2018
12 months to Jun 30, 2018
|
FY2017
12 months to Jun 30, 2017
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Expenses: | |||||
| Cost of revenue | |||||
| Selling, general and administrative expenses | |||||
| Restructuring expenses | |||||
| Litigation provision | |||||
| Total expenses | |||||
| Operating earnings | |||||
| Interest expense | |||||
| Loss from equity method investment | |||||
| Other income, net | |||||
| Earnings before income taxes | |||||
| Provision for income taxes | |||||
| Net earnings from continuing operations | |||||
| Net earnings (loss) from discontinued operations | |||||
| Net earnings | |||||
| Less: net earnings attributable to noncontrolling interest | |||||
| Net earnings attributable to CDK | |||||
| Net earnings (loss) attributable to CDK per share - basic: | |||||
| Continuing operations (in dollars per share) | |||||
| Discontinued operations (in dollars per share) | |||||
| Total net earnings attributable to CDK per share - basic (in dollars per share) | |||||
| Net earnings (loss) attributable to CDK per share - diluted: | |||||
| Continuing operations (in dollars per share) | |||||
| Discontinued operations (in dollars per share) | |||||
| Total net earnings attributable to CDK per share - diluted (in dollars per share) | |||||
| Weighted average common shares outstanding: | |||||
| Basic (shares) | |||||
| Diluted (shares) | |||||
Loading...